11.18.15
Redmond, Wash.-based EndoGastric Solutions (EGS), which makes incisionless procedural therapy for gastroesophageal reflux disease (GERD), has made industry veteran Michael K. Burke chief financial officer. Burke is a seasoned financial executive with over 30 years of experience.
“I am excited to join EGS at such an important time in the company’s development,” Burke said. “Since receiving our CPT [Current Procedural Terminology] code designation, millions of individuals suffering from painful acid reflux symptoms will now have a pathway to the TIF procedure—a safe and effective treatment option not previously available to them. I look forward to working alongside EGS’ leadership team in establishing our transoral, incisionless procedure as a standard of care for a subset of GERD patients that would significantly benefit from this treatment option.”
EGS recently announced the Federal Register has posted coding and payment information specific to the new CPT, allowing patients to more easily receive access to treatment for GERD.
CPT codes are a listing of descriptive terms and identifying codes for reporting medical services and procedures. The purpose of CPT is to provide a uniform language that accurately describes medical, surgical, and diagnostic services, and thereby serves as an effective means for reliable nationwide communication among physicians and other healthcare providers, patients, and third parties. CPT is registered trademark of the American Medical Association.
“Michael is a vital addition to the EGS senior executive leadership team,” said Skip Baldino, president and CEO of EndoGastric Solutions. “Michael brings to EGS deep financial and operational experiences that will serve us well as we continue our efforts to gain greater adoption of our proprietary TIF technology as a beneficial treatment option for a subset of the GERD patient population we serve. As EGS continues to build our franchise with a balanced commercial approach involving robust clinical data expansion, ongoing product development, and increased commercial investments—we are thrilled to have someone of Michael’s caliber spearheading the company’s financial direction.”
Burke has held several leadership positions in finance. He most recently served as senior vice president and chief financial officer of Landauer Inc., a leading global provider of technical and analytical services to the healthcare sector. Prior to this, Burke was the senior vice president and chief financial officer of Albany International Corp., and the executive vice president and chief financial officer of Intermagnetics General Corporation, a medical device company focused on magnetic resonance imaging. He graduated from Lake Forest College with a bachelor’s degree in Economics and completed graduate studies at The Wharton School of the University of Pennsylvania.
“I am excited to join EGS at such an important time in the company’s development,” Burke said. “Since receiving our CPT [Current Procedural Terminology] code designation, millions of individuals suffering from painful acid reflux symptoms will now have a pathway to the TIF procedure—a safe and effective treatment option not previously available to them. I look forward to working alongside EGS’ leadership team in establishing our transoral, incisionless procedure as a standard of care for a subset of GERD patients that would significantly benefit from this treatment option.”
EGS recently announced the Federal Register has posted coding and payment information specific to the new CPT, allowing patients to more easily receive access to treatment for GERD.
CPT codes are a listing of descriptive terms and identifying codes for reporting medical services and procedures. The purpose of CPT is to provide a uniform language that accurately describes medical, surgical, and diagnostic services, and thereby serves as an effective means for reliable nationwide communication among physicians and other healthcare providers, patients, and third parties. CPT is registered trademark of the American Medical Association.
“Michael is a vital addition to the EGS senior executive leadership team,” said Skip Baldino, president and CEO of EndoGastric Solutions. “Michael brings to EGS deep financial and operational experiences that will serve us well as we continue our efforts to gain greater adoption of our proprietary TIF technology as a beneficial treatment option for a subset of the GERD patient population we serve. As EGS continues to build our franchise with a balanced commercial approach involving robust clinical data expansion, ongoing product development, and increased commercial investments—we are thrilled to have someone of Michael’s caliber spearheading the company’s financial direction.”
Burke has held several leadership positions in finance. He most recently served as senior vice president and chief financial officer of Landauer Inc., a leading global provider of technical and analytical services to the healthcare sector. Prior to this, Burke was the senior vice president and chief financial officer of Albany International Corp., and the executive vice president and chief financial officer of Intermagnetics General Corporation, a medical device company focused on magnetic resonance imaging. He graduated from Lake Forest College with a bachelor’s degree in Economics and completed graduate studies at The Wharton School of the University of Pennsylvania.